The first study of the safety and effectiveness of the domestically developed corona virus vaccine in Iran

The first study of the safety and effectiveness of the domestically developed corona virus vaccine (vaccine) in Iran began on Tuesday. Dozens of people are to be planted in this badly affected country. Shifa PharmaD, a state-owned pharmaceutical consortium has developed the vaccine in Iran. Iran has been worst affected by Covid-19 in West Asia.

It is the first vaccine to reach the level of human testing. President Hassan Rouhani has said that Iran is partnering with another country to produce another vaccine that can be tested on humans in February. He did not say anything more than this. More than 1.2 million people have been infected in Iran so far and about 55,000 people have lost their lives.

In the first phase clinical trial, a total of 56 participants will be given two doses of the Iran-made vaccine within two weeks. Hamid Hussaini gave this information related to the test. They reported that the results would be announced about a month after the second dose was given.

The first study of the safety and effectiveness of the domestically developed corona virus vaccine in Iran
The first study of the safety and effectiveness of the domestically developed corona virus vaccine in Iran

Islamabad: Pakistan on Tuesday confirmed the first case of a new type of corona virus reported in Britain. Samples of three travelers who returned from Britain revealed the presence of this fast spreading virus strain. The Health Department of Sindh said that samples of 12 people were taken for genotyping, of which six confirmed corona virus infection.

In a tweet, she said, “The samples of three people returned from Britain match 95 percent of the new strains of Corona found in Britain in the first phase of genotyping.” The department said the provincial government was looking for people exposed to the infected And such people are being sent to segregation. Pakistan has banned the operation of flights from Britain till January 4.